MA49464A - Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants - Google Patents
Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondantsInfo
- Publication number
- MA49464A MA49464A MA049464A MA49464A MA49464A MA 49464 A MA49464 A MA 49464A MA 049464 A MA049464 A MA 049464A MA 49464 A MA49464 A MA 49464A MA 49464 A MA49464 A MA 49464A
- Authority
- MA
- Morocco
- Prior art keywords
- associations
- corresponding processes
- targeted drug
- new compositions
- drug rescue
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762501696P | 2017-05-04 | 2017-05-04 | |
| TW106129169A TW201815387A (zh) | 2016-08-26 | 2017-08-28 | 組成物及其方法 |
| US201862634162P | 2018-02-22 | 2018-02-22 | |
| US201862636099P | 2018-02-27 | 2018-02-27 | |
| US201862635554P | 2018-02-27 | 2018-02-27 | |
| US201862636171P | 2018-02-28 | 2018-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49464A true MA49464A (fr) | 2020-04-29 |
Family
ID=65431106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049464A MA49464A (fr) | 2017-05-04 | 2018-05-03 | Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3618819A4 (https=) |
| JP (2) | JP7514078B2 (https=) |
| KR (2) | KR20200062078A (https=) |
| CN (1) | CN110831584B (https=) |
| AU (2) | AU2018261654A1 (https=) |
| BR (1) | BR112019022902A2 (https=) |
| CA (2) | CA3062452C (https=) |
| IL (1) | IL270326B2 (https=) |
| MA (1) | MA49464A (https=) |
| RU (1) | RU2760558C9 (https=) |
| TW (1) | TWI787260B (https=) |
| WO (1) | WO2018204713A1 (https=) |
| ZA (1) | ZA201908006B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA49464A (fr) * | 2017-05-04 | 2020-04-29 | Exciva GmbH | Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants |
| TW202102219A (zh) * | 2019-03-18 | 2021-01-16 | 美商艾賓爾製藥公司 | 使用氘化右旋美沙芬(dextromethorphan)及奎尼丁(quinidine)治療精神分裂症之負面徵候之方法 |
| JP7400818B2 (ja) * | 2019-06-06 | 2023-12-19 | Jsr株式会社 | 感放射線性樹脂組成物、レジストパターン形成方法及び化合物 |
| KR20240096817A (ko) | 2020-05-19 | 2024-06-26 | 사이빈 아이알엘 리미티드 | 중수소화된 트립타민 유도체 및 사용 방법 |
| CN116473077B (zh) * | 2023-05-08 | 2025-04-11 | 广东方中高新材料有限公司 | 一种n,n配位的镓配合物抗菌剂的合成和应用 |
| CN116473073A (zh) * | 2023-05-08 | 2023-07-25 | 广东方中高新材料有限公司 | 一种含镓配合物的吡唑醚菌酯增效悬浮制剂及其制备方法 |
| CN119432479B (zh) * | 2023-08-04 | 2025-10-03 | 中国石油天然气股份有限公司 | 柴油机润滑油组合物及其制备方法 |
| CN120987847B (zh) * | 2024-11-29 | 2026-02-17 | 江苏恩华药业股份有限公司 | 一种氢溴酸右美沙芬的制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4241065A (en) * | 1979-07-02 | 1980-12-23 | E. I. Du Pont De Nemours And Company | Fluoro analogs of hydrocodone and oxycodone useful as analgesics, narcotic antagonists or both |
| US4950658A (en) * | 1988-12-06 | 1990-08-21 | Board Of Trustees Of Southern Illinois Univ. | Method of medical treatment of Alzheimer's disease |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US6207674B1 (en) * | 1999-12-22 | 2001-03-27 | Richard A. Smith | Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| US6335371B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Method for inducing cognition enhancement |
| TWI326214B (en) * | 2002-07-17 | 2010-06-21 | Avanir Pharmaceuticals Inc | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| US20070099947A1 (en) * | 2005-11-03 | 2007-05-03 | Alkermes, Inc. | Methods and compositions for the treatment of brain reward system disorders by combination therapy |
| CA2641392A1 (en) | 2006-02-03 | 2007-08-16 | Avanir Pharmaceuticals | Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders |
| US7973049B2 (en) * | 2007-05-01 | 2011-07-05 | Concert Pharmaceuticals Inc. | Morphinan compounds |
| EP2162135A4 (en) * | 2007-05-21 | 2012-02-22 | Reviva Pharmaceuticals Inc | COMPOSITIONS, SYNTHESIS AND METHOD FOR THE APPLICATION OF ATTAINED CHINOLINONE-BASED ANTIPSYCHOTICS |
| US8017623B2 (en) * | 2008-07-03 | 2011-09-13 | Trinity Laboratories, Inc. | Dextromethorphan hydrochloride |
| US9737531B2 (en) * | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| EP2964022B1 (en) * | 2013-03-07 | 2019-11-06 | Mindlab LLC | Pain medicine combination and uses thereof |
| AU2014232869A1 (en) * | 2013-03-15 | 2015-10-08 | Patrizia Fanara | Methods for monitoring the effects of an agent in sujects with motoneuron disease with dementia |
| CN117427077A (zh) * | 2014-09-14 | 2024-01-23 | 阿瓦尼尔制药股份有限公司 | 用于治疗痴呆中的激越行为的包含右美沙芬化合物和奎尼丁的药物组合物 |
| US11103499B2 (en) * | 2016-08-26 | 2021-08-31 | EXCIVA (UG) (haftungsbeschränkt) | Compositions and methods thereof |
| MA49464A (fr) * | 2017-05-04 | 2020-04-29 | Exciva GmbH | Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants |
-
2018
- 2018-05-03 MA MA049464A patent/MA49464A/fr unknown
- 2018-05-03 BR BR112019022902A patent/BR112019022902A2/pt not_active Application Discontinuation
- 2018-05-03 KR KR1020197035796A patent/KR20200062078A/ko not_active Ceased
- 2018-05-03 RU RU2019137004A patent/RU2760558C9/ru active
- 2018-05-03 EP EP18794381.6A patent/EP3618819A4/en active Pending
- 2018-05-03 CA CA3062452A patent/CA3062452C/en active Active
- 2018-05-03 WO PCT/US2018/030978 patent/WO2018204713A1/en not_active Ceased
- 2018-05-03 CN CN201880037396.3A patent/CN110831584B/zh active Active
- 2018-05-03 JP JP2019560216A patent/JP7514078B2/ja active Active
- 2018-05-03 KR KR1020217033764A patent/KR102444803B1/ko active Active
- 2018-05-03 AU AU2018261654A patent/AU2018261654A1/en not_active Abandoned
- 2018-05-03 CA CA3138116A patent/CA3138116A1/en active Pending
- 2018-05-04 TW TW107115320A patent/TWI787260B/zh active
-
2019
- 2019-10-31 IL IL270326A patent/IL270326B2/en unknown
- 2019-12-02 ZA ZA2019/08006A patent/ZA201908006B/en unknown
-
2021
- 2021-08-13 AU AU2021215274A patent/AU2021215274B2/en active Active
-
2023
- 2023-07-21 JP JP2023119151A patent/JP2023143940A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018261654A1 (en) | 2019-11-14 |
| KR102444803B1 (ko) | 2022-09-19 |
| KR20210130827A (ko) | 2021-11-01 |
| RU2760558C9 (ru) | 2022-02-22 |
| AU2021215274A1 (en) | 2021-09-02 |
| CA3062452C (en) | 2023-10-24 |
| CN110831584A (zh) | 2020-02-21 |
| RU2019137004A3 (https=) | 2021-06-04 |
| IL270326B (en) | 2022-10-01 |
| TW201842902A (zh) | 2018-12-16 |
| IL270326B2 (en) | 2023-02-01 |
| KR20200062078A (ko) | 2020-06-03 |
| JP7514078B2 (ja) | 2024-07-10 |
| CN110831584B (zh) | 2023-03-10 |
| WO2018204713A1 (en) | 2018-11-08 |
| TWI787260B (zh) | 2022-12-21 |
| RU2019137004A (ru) | 2021-06-04 |
| CA3138116A1 (en) | 2018-11-08 |
| EP3618819A4 (en) | 2021-01-20 |
| ZA201908006B (en) | 2021-04-28 |
| JP2020518617A (ja) | 2020-06-25 |
| BR112019022902A2 (pt) | 2020-05-19 |
| IL270326A (https=) | 2018-05-03 |
| RU2760558C2 (ru) | 2021-11-29 |
| JP2023143940A (ja) | 2023-10-06 |
| CA3062452A1 (en) | 2018-11-08 |
| AU2021215274B2 (en) | 2022-11-03 |
| EP3618819A1 (en) | 2020-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA49464A (fr) | Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants | |
| EP3313989C0 (en) | MODIFIED CRISPR RNA AND MODIFIED SINGLE CRISPR RNA AND USES THEREOF | |
| MA49858A (fr) | Composés, compositions et procédés | |
| DK3297637T3 (da) | Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf | |
| DK3580561T3 (da) | Hla-baserede metoder, sammensætninger og anvendelse heraf | |
| HUE067016T2 (hu) | Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások | |
| HUE053737T2 (hu) | Piridopirrolokinoxalin vegyületek, készítményeik és alkalmazásaik | |
| EP3676297A4 (en) | COMPOUNDS, COMPOSITIONS, AND PROCEDURES | |
| EP3551238A4 (en) | DEODORIZING COMPOSITIONS, OSTOMA DEVICES AND THEIR USES | |
| HUE049081T2 (hu) | GP120 elleni neutralizáló antitestek és alkalmazásuk | |
| EP3313404A4 (en) | THERAPEUTIC COMPOSITIONS, COMBINATIONS AND METHODS OF USE | |
| EP3599868C0 (en) | HERBICIDE MIXTURE, COMPOSITION AND PROCESS | |
| EP3500255A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR EYE AND RELATED USE | |
| EP3535204A4 (en) | SELF-SERVICE STORAGE FACILITY, MANUFACTURING, AND METHODOLOGY | |
| EP3685828A4 (en) | OPHTHALMIC PHARMACEUTICAL COMPOSITION, OPHTHALMIC KIT, AND PHARMACEUTICAL USE THEREOF | |
| EP3617287A4 (en) | THICKENING AGENT, COMPOSITION AND SHEET | |
| EP3515897A4 (en) | PIPERAZINE CARBAMATES AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
| EP3562942A4 (en) | MODIFIED CRISPR-RNA AND ITS USES | |
| HUE060805T2 (hu) | Piridinamin-piridon és pirimidinamin-piridon vegyületek | |
| EP3434285A4 (en) | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | |
| DK3612579T3 (da) | Pultrudat, fremstilling og anvendelse heraf | |
| LT3169307T (lt) | Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną | |
| EP3654982A4 (en) | 1,8-NAPHTHYRIDINONE COMPOUNDS AND THEIR USES | |
| HUE070649T2 (hu) | Benzimidazol-származékok és felhasználásuk | |
| EP3609504A4 (en) | NEW OXABOROLE ANALOGUES AND USES OF THE LATEST |